ABBV
AbbVie Inc
265.20$
+0.3%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +14.5% | +12.2% | +10.1% | +16.1% | +1.6% | +37.7% | +22.7% | +3.3% | -6.4% | +3.7% | +8.6% | |
| – | +1.7% | +29.6% | +20.7% | +9.6% | -3.6% | +106.8% | +13.4% | -0.2% | +17.2% | -17.2% | +7.7% | |
| – | +18.2% | +7.9% | +6.9% | +18.2% | +3.2% | +17.8% | +27.4% | +4.9% | -16.6% | +16.3% | +8.9% | |
| – | +21.5% | +3.4% | +16.3% | +101.6% | -36.8% | +14.2% | +3.8% | -19.1% | +17.9% | +66.7% | -28.9% | |
| – | -7.5% | +2.3% | +6.5% | +15.8% | -6.6% | +38.1% | +27.0% | +29.4% | -19.3% | +3.6% | +26.3% | |
| – | -10.7% | -3.3% | +11.1% | +60.4% | -31.1% | +48.3% | +9.3% | +8.1% | -6.1% | +43.3% | -24.5% | |
| – | +121.0% | +23.9% | +2.2% | -33.1% | +103.4% | -12.5% | +57.7% | +1.1% | -29.6% | -28.4% | +119.9% | |
| – | +67.6% | +45.6% | +9.8% | +17.2% | +32.3% | +37.6% | -1.3% | -8.0% | -0.3% | +26.3% | +3.0% | |
| – | +180.5% | +18.6% | -2.0% | -32.7% | +62.1% | -59.7% | +282.3% | +3.8% | -53.6% | -40.5% | +77.5% | |
| – | +152.3% | +28.6% | +25.2% | -120.3% | – | -325.0% | – | +13.3% | -15.6% | -141.4% | – | |
| – | +190.0% | +15.7% | -10.8% | +7.1% | +38.6% | -41.4% | +150.0% | +2.5% | -58.9% | -12.0% | -1.2% | |
| – | +128.8% | +23.4% | +2.5% | -19.9% | +47.1% | +0.8% | +94.2% | +1.0% | -29.0% | -13.2% | +18.2% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.